These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29086207)

  • 1. Identification of Ideal Multi-targeting Bioactive Compounds Against Mur Ligases of Enterobacter aerogenes and Its Binding Mechanism in Comparison with Chemical Inhibitors.
    Chakkyarath V; Natarajan J
    Interdiscip Sci; 2019 Mar; 11(1):135-144. PubMed ID: 29086207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization.
    Perdih A; Hrast M; Pureber K; Barreteau H; Grdadolnik SG; Kocjan D; Gobec S; Solmajer T; Wolber G
    J Comput Aided Mol Des; 2015 Jun; 29(6):541-60. PubMed ID: 25851408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
    Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
    Bioorg Med Chem; 2014 Aug; 22(15):4124-34. PubMed ID: 24953950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy.
    Shanmugam A; Natarajan J
    J Mol Model; 2012 Jun; 18(6):2659-72. PubMed ID: 22102165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
    Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S
    Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of Mur ligases as an antibacterial target.
    Kouidmi I; Levesque RC; Paradis-Bleau C
    Mol Microbiol; 2014 Oct; 94(2):242-53. PubMed ID: 25130693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and biochemical characterization of Mur ligases from Staphylococcus aureus.
    Patin D; Boniface A; Kovač A; Hervé M; Dementin S; Barreteau H; Mengin-Lecreulx D; Blanot D
    Biochimie; 2010 Dec; 92(12):1793-800. PubMed ID: 20659527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review.
    Sangshetti JN; Joshi SS; Patil RH; Moloney MG; Shinde DB
    Curr Pharm Des; 2017; 23(21):3164-3196. PubMed ID: 28201974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the interaction mechanism between potential inhibitor and multi-target Mur enzymes of mycobacterium tuberculosis using molecular docking, molecular dynamics simulation, principal component analysis, free energy landscape, dynamic cross-correlation matrices, vector movements, and binding free energy calculation.
    Kumari M; Singh R; Subbarao N
    J Biomol Struct Dyn; 2022; 40(24):13497-13526. PubMed ID: 34662260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mur ligases inhibitors with azastilbene scaffold: Expanding the structure-activity relationship.
    Hrast M; Frlan R; Knez D; Zdovc I; Barreteau H; Gobec S
    Bioorg Med Chem Lett; 2021 May; 40():127966. PubMed ID: 33744441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational and Biophysical Approaches to Identify Cell Wall-Associated Modulators in Salmonella enterica serovar Typhi.
    Kumar M; Haque MA; Kaur P
    Methods Mol Biol; 2024; 2727():35-55. PubMed ID: 37815707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening for potential inhibitors of bacterial MurC and MurD ligases.
    Tomašić T; Kovač A; Klebe G; Blanot D; Gobec S; Kikelj D; Mašič LP
    J Mol Model; 2012 Mar; 18(3):1063-72. PubMed ID: 21667288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential of Mur Enzymes as Targets for Antimicrobial Drug Discovery.
    Kumar D; Sarkar N; Roy KK; Bisht D; Kumar D; Mandal B; Rajagopal M; Dey YN
    Curr Drug Targets; 2023; 24(8):627-647. PubMed ID: 37291783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MurG glycosyltransferase provides an oligomeric scaffold for the cytoplasmic steps of peptidoglycan biosynthesis in the human pathogen Bordetella pertussis.
    Laddomada F; Miyachiro MM; Jessop M; Patin D; Job V; Mengin-Lecreulx D; Le Roy A; Ebel C; Breyton C; Gutsche I; Dessen A
    Sci Rep; 2019 Mar; 9(1):4656. PubMed ID: 30874582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of ATP-dependent Mur ligases involved in the biogenesis of cell wall peptidoglycan in Mycobacterium tuberculosis.
    Munshi T; Gupta A; Evangelopoulos D; Guzman JD; Gibbons S; Keep NH; Bhakta S
    PLoS One; 2013; 8(3):e60143. PubMed ID: 23555903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target.
    Hervin V; Roy V; Agrofoglio LA
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases.
    Hrast M; Rožman K; Ogris I; Škedelj V; Patin D; Sova M; Barreteau H; Gobec S; Grdadolnik SG; Zega A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1010-1017. PubMed ID: 31072165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach.
    Perdih A; Kovac A; Wolber G; Blanot D; Gobec S; Solmajer T
    Bioorg Med Chem Lett; 2009 May; 19(10):2668-73. PubMed ID: 19369074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex Formation between Mur Enzymes from
    Miyachiro MM; Granato D; Trindade DM; Ebel C; Paes Leme AF; Dessen A
    Biochemistry; 2019 Jul; 58(30):3314-3324. PubMed ID: 31264408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-targeted therapy for leprosy: insilico strategy to overcome multi drug resistance and to improve therapeutic efficacy.
    Anusuya S; Natarajan J
    Infect Genet Evol; 2012 Dec; 12(8):1899-910. PubMed ID: 22981928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.